Client & Alumni News

Particle Sciences Acquired by Lubrizol

The Lubrizol Corporation announced that it has acquired Bethlehem-based Particle Sciences, a global leader in complex formulations including drug eluting device product development as well as sterile and particulate drug products. Lubrizol has approximately 9,000 employees worldwide and 2014 revenues of $7 billion. The acquisition further expands Lubrizol LifeSciences’ pharmaceutical development capabilities. Particle Sciences will retain its company name and local employees, according to Particle Sciences CEO Mark Mitchnick, and hopes to continue to grow in the Lehigh Valley. Read more: